is the compounded semaglutide safe FDA warns against using Compounded Semaglutide vs. Ozempic: Effectiveness

Given that several further dual agonists are coming closer to becoming licenced, such as mazdutide and survodutide, with many more in development [15], combining licenced dual agonists with developing mono-agonists may be a faster way to develop effective treatments achieving triple agonism

Clin Res Hepatol Gastroenterol 2021;45:101568.ArticlePubMed 119

Noncompliance may result in significant legal and financial consequences, including regulatory action

Retatrutides Phase 2 average of 24.2% at 48 weeks is entering that territory

But the trade-off is better adherence: when patients tolerate their medication, they stick with it

Insights from TRIUMPH-1 Phase 3 Trial On May 21, 2026, Eli Lilly released encouraging data from the TRIUMPH-1 Phase 3 trial, which examined retatrutide in obese or overweight individuals